Boston Scientific Corp., of Natick, Mass., has entered into a four-year exclusive marketing agreement with Bladder Health Network (BHN), a privately held company headquartered in Jackson, Miss., that offers advanced testing solutions for urinary incontinence.

As part of the agreement, Boston Scientific’s Urology and Women’s Health Division will market BHN’s female urodynamic testing solutions to U.S. health care providers.

From the May 01, 2010 Issue of Renal and Urology News

Topics:

FDA